Entorhinal cortex-based metabolic profiling of chronic restraint stress mice model of depression

Abstract

Despite that millions of people suffer from major depressive disorder (MDD), the mechanism underlying MDD remains elusive. Recently, it has been reported that entorhinal cortex (EC) functions on the regulation of depressive-like phenotype relying on the stimulation of glutamatergic afferent from EC to hippocampus. Based on this, we used liquid chromatography-tandem mass spectrometry method to explore metabolic alterations in the EC of mice after exposed to chronic restraint stress (CRS). Molecular validation was conducted via the application of western blot and RT-qPCR. Through this study, we found significant upregulation of glutamate, ornithine aspartic acid, 5-hydroxytryptophan, L-tyrosine and norepinephrine in CRS group, accompanied with downregulation of homovanillic acid. Focusing on these altered metabolic pathways in EC, we found that gene levels of GAD1, GLUL and SNAT1 were increased. Upregulation of SERT and EAAT2 in protein expression level were also validated, while no significant changes were found in TH, AADC, MAOA, VMAT2, GAD1, GLUL and SNAT1. Our findings firstly provide evidence about the alteration of metabolites and related molecules in the EC of mice model of depression, implying the potential mechanism in MDD pathology.

Validity of chronic restraint stress for modeling anhedonic-like behavior in rodents: a systematic review and meta-analysis

“…Ultimately, 33 articles were selected. One article was identified by manually checking reference lists, and therefore a total of 34 articles 20 – 22 , 24 – 54 were enrolled in this meta-analysis.…”

Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine

“…Previous studies found that depression was more frequently diagnosed in DM patients compared to the matched healthy controls; about 15% of DM patients met the criteria for comorbid depression [ 9 , 10 ]. Depression is a seriously debilitating mental illness with unclear pathogenesis and no objective diagnostic methods [ 11 – 13 ]. The depressed DM patients often show some negative coping strategies that can affect the outcomes of treatment, resulting in the decreased treatment adherence, increased diabetes fatalism and low-quality of life [ 14 ].…”